154 related articles for article (PubMed ID: 22130532)
21. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
Sakakibara S; Tosato G
J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
23. Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6.
Hu F; Nicholas J
J Virol; 2006 Nov; 80(21):10874-8. PubMed ID: 16956953
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration.
Giffin L; West JA; Damania B
mBio; 2015 Dec; 6(6):e01499-15. PubMed ID: 26646010
[TBL] [Abstract][Full Text] [Related]
25. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.
Aoki Y; Narazaki M; Kishimoto T; Tosato G
Blood; 2001 Nov; 98(10):3042-9. PubMed ID: 11698289
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression.
Kang JG; Pripuzova N; Majerciak V; Kruhlak M; Le SY; Zheng ZM
J Virol; 2011 Mar; 85(6):2620-30. PubMed ID: 21209110
[TBL] [Abstract][Full Text] [Related]
27. Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display.
Kovaleva M; Bussmeyer I; Rabe B; Grötzinger J; Sudarman E; Eichler J; Conrad U; Rose-John S; Scheller J
J Virol; 2006 Sep; 80(17):8510-20. PubMed ID: 16912301
[TBL] [Abstract][Full Text] [Related]
28. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
[TBL] [Abstract][Full Text] [Related]
29. Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus.
Zhang YJ; Bonaparte RS; Patel D; Stein DA; Iversen PL
Mol Cancer Ther; 2008 Mar; 7(3):712-20. PubMed ID: 18347156
[TBL] [Abstract][Full Text] [Related]
30. Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells.
Hoischen SH; Vollmer P; März P; Ozbek S; Götze KS; Peschel C; Jostock T; Geib T; Müllberg J; Mechtersheimer S; Fischer M; Grötzinger J; Galle PR; Rose-John S
Eur J Biochem; 2000 Jun; 267(12):3604-12. PubMed ID: 10848977
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells.
Subramanian R; Sehgal I; D'Auvergne O; Kousoulas KG
J Virol; 2010 Feb; 84(4):1704-14. PubMed ID: 19955303
[TBL] [Abstract][Full Text] [Related]
32. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
[TBL] [Abstract][Full Text] [Related]
33. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
[TBL] [Abstract][Full Text] [Related]
34. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
Rost S; Fregin A; Ivaskevicius V; Conzelmann E; Hörtnagel K; Pelz HJ; Lappegard K; Seifried E; Scharrer I; Tuddenham EG; Müller CR; Strom TM; Oldenburg J
Nature; 2004 Feb; 427(6974):537-41. PubMed ID: 14765194
[TBL] [Abstract][Full Text] [Related]
35. Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system.
Wajih N; Sane DC; Hutson SM; Wallin R
J Biol Chem; 2005 Mar; 280(11):10540-7. PubMed ID: 15640149
[TBL] [Abstract][Full Text] [Related]
36. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit.
Molden J; Chang Y; You Y; Moore PS; Goldsmith MA
J Biol Chem; 1997 Aug; 272(31):19625-31. PubMed ID: 9235971
[TBL] [Abstract][Full Text] [Related]
37. Identification of VKORC1 interaction partners by split-ubiquitin system and coimmunoprecipitation.
Schaafhausen A; Rost S; Oldenburg J; Müller CR
Thromb Haemost; 2011 Feb; 105(2):285-94. PubMed ID: 21103663
[TBL] [Abstract][Full Text] [Related]
38. Vitamin K epoxide reductase: homology, active site and catalytic mechanism.
Goodstadt L; Ponting CP
Trends Biochem Sci; 2004 Jun; 29(6):289-92. PubMed ID: 15276181
[TBL] [Abstract][Full Text] [Related]
39. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle.
Oldenburg J; Bevans CG; Müller CR; Watzka M
Antioxid Redox Signal; 2006; 8(3-4):347-53. PubMed ID: 16677080
[TBL] [Abstract][Full Text] [Related]
40. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways.
Osborne J; Moore PS; Chang Y
Hum Immunol; 1999 Oct; 60(10):921-7. PubMed ID: 10566591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
